top of page

Title: Australia stocks higher at close of trade; S&P/ASX 200 up 0.05%

  • Writer: analysiswatch
    analysiswatch
  • Apr 20, 2022
  • 1 min read

Apr 20, 2022 03:45AM ET


By: AnalysisWatch


Australian shares rose after the close on Wednesday as gains in healthcare, consumer staples, and consumer cyclical sectors led stocks higher.


At the close of trading in Sydney, the S & P/ASX 200 was up 0.05%, hitting a new 3-month high.


The best performers in the S & P/ASX 200 were Ramsay Health Care Ltd., which rose 24.24%, or 15.61 points, to close at 80.00. Meanwhile, Pro Medicus Ltd gained 5.20 per cent, or 2.55 points, to close at 51.61, while United Malt Group Ltd gained 4.48 per cent, or 0.18 points, to 4.20 in late trading.


The worst performer was Hub24 Ltd, which fell 6.47%, or 1.68 points, to close at 24.28. Regis Resources Ltd fell 6.20% or 0.15 points to 2.27, while Gold Road Resources Ltd fell 4.06% or 0.07 points to 1.65.


On the Sydney Stock Exchange, falling shares outweighed rising ones by 771 to 669, and 386 ended unchanged.


Ramsay Health Care Ltd shares rose 24.24%, or 15.61 to 80.00, to a 52-week high.


The S&P/ASX 200 VIX, which measures implied volatility of S&P/ASX 200 options, increased 0.59% to 13.07.


Gold futures for June delivery fell 0.72%, or 14.05, to $1,944.95 a troy ounce. Elsewhere in commodities trading, crude oil for June delivery rose 1.44%, or 1.47, to $103.52 a barrel, while the June Brent oil contract rose 1.40%, or 1.50, to $108.75 a barrel.


AUD/USD increased by 0.75 percent to 0.74 percent, while AUD/JPY increased by 0.47 percent to 95.44.


Futures on the US dollar index fell 0.25% to 100.71.


Comments


2b94f773-a237-4da7-a599-6b42314ed9e6.png

Risk Disclosure: AnalysisWatch will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Currency trading on margin involves high risk, and is not suitable for all investors. Before deciding to trade foreign exchange or any other financial instrument you should carefully consider your investment objectives, level of experience, and risk appetite.
AnalysisWatch would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore AnalysisWatch doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.

bottom of page